News

Paracetamol overdose care warning

28 March 2014

New paracetamol overdose treatment costs millions but doesn’t save many lives suggests study published in British Journal of Clinical Pharmacology

New BJP article on dangers of ecstasy and mephedrone

18 March 2014

Contrary to popular belief among recreational drug users, mephedrone has several important differences when compared with MDMA, commonly known as ecstasy. These differences mean that mephedrone could leave a user with acute withdrawal symptoms and indicate that it may have a higher potential for developing dependence than MDMA according to a study published in British Journal of Pharmacology.

BPS President Elect welcomes improved access to medicines in Scotland

28 February 2014

BPS President Elect Professor David Webb review of the way drugs are approved for the Scottish Medicines Consortium (SMC) welcomes improved access to medicines but estimates significant financial impact on NHS Scotland.  

Guidelines call for more people to be put on statins

13 February 2014

BPS Fellow Professor Simon Maxwell responds to the draft guidelines for the NHS in England recommending that more people should be put on cholesterol-lowering statin drugs to protect them against heart attacks and strokes. Professor Maxwell commentsthat, 'patients should be helped to make a truly informed decision about the benefits and risks of taking long-term preventative therapy that will not make them feel any better in the short term.'

STC report on women in scientific careers

06 February 2014

Science and Technology Select Committee report on women in scientific careers published today (6 February 2014). BPS highlights that "many women in STEM suffer bias due to expectation, in that the potential for a woman to take maternity leave or to require flexible working in future can impact the judgement of interviewers." The report concludes that universities need to do more to keep women in science.

Does taking multiple medicines increase your risk of being admitted to hospital? Yes and No

16 January 2014

BJCP Press release

Patients with a single illness who take many drugs have an increased risk of being admitted to hospital, but for patients with multiple conditions, taking many medicines is now associated with a near-normal risk of admission. This is the key finding of work published in the British Journal of Clinical Pharmacology. Doctors call the situation where people take many drugs ‘polypharmacy’, a state of affairs that is becoming increasingly common in part because we have more elderly people and also a rising number of people are being diagnosed with multiple health conditions.

Call for symposia: Pharmacology 2014 - Deadline Extended

15 January 2014

The BPS Meetings Committee is seeking symposia proposals for Pharmacology 2014 (formerly known as the BPS Winter Meeting) which will be held from Tuesday 16 to Thursday 18 December 2014. Please send your proposals including all the information listed below to the BPS office by Monday 27 January 2014:

Drug Discovery of the Year awarded to team behind trametinib

19 December 2013

First-of-its-kind treatment for skin cancer offers hope for patients and their families

Thursday 19 December 2013, London UK: The British Pharmacological Society proudly announces that its Drug Discovery of the Year award has been won by the team at GlaxoSmithKline (GSK) responsible for the development of trametinib – a new treatment for malignant melanoma (a type of skin cancer).

Ground-breaking medic wins British Pharmacological Society’s Lilly Prize

19 December 2013

Announced as part of Prize-Giving event where over £10,000 was awarded

Wednesday 18 December 2013, London UK: The British Pharmacological Society has announced that the Society’s 2013 Lilly Prize has been won by Professor Nick Bateman, for his major contribution to clinical pharmacology. The award will be presented at the Society’s Annual Dinner and Prize-Giving on Wednesday 18 December.

MPs, peers and scientists come together to put UK pharmacology on the map

17 December 2013

New initiative recognizes outstanding scientific achievements at sites in Glasgow, Cheshire, Oxford and London

Monday 16 December 2013, London UK: Four sites of special scientific interest linked to discoveries and contributions in pharmacology have won recognition in a vote by MPs, peers and senior members of the scientific community. On behalf of the British Pharmacological Society, Andrew Miller MP revealed the names of the winning sites at a special parliamentary reception held this evening:

Page:   1 2 3 4 5 6 Next
Search the News

Top Navigation

Search Area

Search the Site
Advanced Search

Members' Login Area

Members' Login U: P:

Need Help?